Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP2 | P08253 | 3/20 | 0.33 |
| ▸ | MMP9 | P14780 | 3/20 | 0.33 |
| ▸ | MMP14 | P50281 | 3/20 | 0.33 |
| ▸ | MMP8 | P22894 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | PKM | P14618 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18099388 | 0.82 | BDKRB1 (0.36) | MMP2MMP9MMP14MMP8ALDH1A1 | |
| SCHEMBL230593 | 0.77 | L3MBTL1 (0.41) | — | |
| SCHEMBL9644015 | 0.71 | L3MBTL1 (0.38) | ALDH1A1LMNA | |
| SCHEMBL16711675 | 0.69 | L3MBTL1 (0.33) | — | |
| SCHEMBL18092295 | 0.67 | CA1 (0.30) | — | |
| SCHEMBL21781851 | 0.66 | L3MBTL1 (0.41) | ALDH1A1 | |
| SCHEMBL1952351 | 0.66 | SMN1; SMN2 (0.36) | ALDH1A1 | |
| SCHEMBL29329710 | 0.66 | SMN1; SMN2 (0.36) | ALDH1A1 | |
| SCHEMBL1301565 | 0.66 | L3MBTL1 (0.37) | ALDH1A1 | |
| SCHEMBL22693775 | 0.65 | THRB (0.42) | ALDH1A1LMNAGAAPKM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9562114-B2 | Cyclic carbonate azide | AKZO NOBEL CHEMICALS INTERNATIONAL B.V. (NL) | 2017-02-07 | — | — | US | disclosed |
| US-20160280805-A1 | Cyclic Carbonate Azide | WILMINGTON TRUST (LONDON) LIMITED, AS COLLATERAL AGENT (GB) | 2016-09-29 | — | — | US | disclosed |
| EP-3066088-A1 | CYCLIC CARBONATE AZIDE | Akzo Nobel Chemicals International B.V. (NL) | 2016-09-14 | — | — | EP | disclosed |
| WO-2015067532-A1 | CYCLIC CARBONATE AZIDE | AKZO NOBEL CHEMICALS INTERNATIONAL B.V. (NL) | 2015-05-14 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160280805-A1 | Cyclic Carbonate Azide | ATXN2L, ATXN10, CYCS | MMP2 4215/4885MMP9 3133/4885MMP14 4304/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.